Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Pathogen adhesion to intestinal epithelium” is the initial step in the colonization and infection by enteric pathogens, involving the interaction of microbial surface molecules (adhesins) with host cell structures (such as glycoproteins and glycolipids on intestinal epithelial cells)[1][2]. This process allows pathogens to establish themselves in the gut, often overcoming host defenses like the mucus layer, antimicrobial peptides, and epithelial turnover[1][2][4]. While critical for the pathogenesis of many infectious diseases, the process itself is not a singular molecular target, but rather a composite biological event implicating various host and microbial factors.
Prevention of bacterial adhesion (e.g., via probiotics, mucus enhancement, anti-adhesive agents like certain dietary fibers or antibodies) Reinforcement of mucus layer or tight junctions Modulation of microbiota to inhibit pathogenic colonization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen adhesion to intestinal epithelium.